Finance, mergers and appointments
Finance, mergers and appointments
Vertex to acquire Crinetics Pharmaceuticals for $10 billion
Vertex Pharmaceuticals and Crinetics Pharmaceuticals, a global pharmaceutical company focused on the discovery, development and commercialisation of novel therapeutics for endocrine diseases, have entered into...
Finance, mergers and appointments
Cumberland Pharmaceuticals closes strategic transaction with Apotex
Cumberland Pharmaceuticals has made an agreement with subsidiary of Apotex Health, a Canadian-based pharmaceutical company, to integrate their branded US businesses. Under the terms...
Drug Discovery & Development
Sanyou Bio and Baiyunshan Xihe join forces to advance innovative radiopharmaceuticals and radiodiagnostics
Sanyou Biopharmaceutical and Guangzhou Baiyunshan Xihe have signed a strategic cooperation agreement.
This partnership will focus on the co-development of novel radiopharmaceuticals and radiodiagnostic products,...
Finance, mergers and appointments
Codis to acquire Catalent’s Nottingham, UK facility to create Europe’s leading end-to-end spray dry capability
Codis, a global contract development and manufacturing organisation (CDMO) specialising in spray drying, amorphous solid dispersions (ASDs) and advanced particle engineering solutions, has entered...
Pharma Delivery and Supply Chain
Vector Science & Therapeutics announces landmark exclusive cGMP manufacturing agreement with LyoGenesis Plus for its proprietary peptide portfolio
Vector Science & Therapeutics Chas entered an exclusive licensing and manufacturing agreement with LyoGenesis Plus, a cGMP lyophilisation and manufacturing partner based in Mequon,...
Finance, mergers and appointments
Helix announces multi-year agreement with AstraZeneca to support genomic research for drug discovery and development
Helix, a leading enterprise genomics company, has announced a multi-year relationship with AstraZeneca, a global biopharmaceutical company. Under this agreement AstraZeneca will gain access...
Finance, mergers and appointments
Evonik invests US$100 million to upgrade its US drug substance contract manufacturing site
Evonik is making a significant investment to strengthen manufacturing capabilities at its Lafayette (Tippecanoe), Indiana facility.
Over the next five years, the company will invest...
Finance, mergers and appointments
Myricx Bio to be acquired by Novartis to advance next-generation ADC payloads for oncology with novel NMTi platform
Myricx Bio, a UK-headquartered biotech company focusing on the discovery and development of a novel class of payloads for antibody-drug conjugates (ADCs), has reached an...
- Advertisement -
- Advertisement -
- Advertisement -
- Advertisement -
Latest stories
© 2026 Pharma Press Publishing.